No correlation ultrasonographic and clinical finding could be found.
Clinical studies find prostaglandin treatment increases uveoscleral outflow, but do not agree whether trabecular outflow increases.
Clinical studies find a higher susceptibility for diabetic patients to acquire infections.
More important, none of the new independent clinical studies found these risks to be clinically significant.
But well-designed clinical trials found increased death rates among people who take them as supplements.
One clinical trial found that Onrigin increased deaths threefold compared with a placebo.
The clinical trial found it significantly slowed the progression of cancer but did not significantly extend life.
A clinical trial found that adding Avastin to the drug paclitaxel nearly doubled the time before tumors worsened.
Clinical trials found Mosquirix to be both safe and effective, providing 39% efficacy at preventing clinical cases of malaria over the course of a four-year trial.
A large clinical trial found that T-DM1 led to better survival rates and fewer side effects than the standard treatment.
